ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,29355
0,00%
Bitcoin
69.264,59
-0,06%
Brent Oil
79,395
0,00%
Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Progenics Pharmaceuticals Inc (PGNX)

  7. Progenics Pharmaceuticals Inc (PGNX) Notícias

PGNX

Progenics Pharmaceuticals (PGNX)

Progenics Pharmaceuticals Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PGNX
DataHoraFonteTítuloCódigoCompanhia
08/02/202214:01Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/06/202017:50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202009:29Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202009:11Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202008:55Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
22/06/202008:00Business WireLantheus Completes Merger with ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
17/06/202018:33PR Newswire (US)Independent Bank Group Set to Join S&P SmallCap 600NASDAQ:PGNXProgenics Pharmaceuticals Inc
16/06/202017:05GlobeNewswire Inc.Progenics Stockholders Approve Merger with LantheusNASDAQ:PGNXProgenics Pharmaceuticals Inc
27/05/202020:53PR Newswire (US)SHAREHOLDER ALERT: WeissLaw LLP Investigates Progenics Pharmaceuticals, Inc.NASDAQ:PGNXProgenics Pharmaceuticals Inc
18/05/202009:30GlobeNewswire Inc.Progenics to Present Results from the Phase 3 CONDOR Trial of PyL™ (18F-DCFPyL) in Prostate Cancer at the American Society ...NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/05/202010:13Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
12/05/202017:33Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:PGNXProgenics Pharmaceuticals Inc
08/05/202018:14PR Newswire (US)Progenics Class Action: Halper Sadeh LLP Announces Filing Of Shareholder Class Action Lawsuit Against Progenics Pharmaceutica...NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202017:09Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PGNXProgenics Pharmaceuticals Inc
07/05/202008:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces First Quarter 2020 Financial Results and Business UpdateNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202018:01Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PGNXProgenics Pharmaceuticals Inc
23/04/202009:30GlobeNewswire Inc.Progenics Pharmaceuticals Sets First Quarter 2020 Financial Results and Business Update Call for May 7NASDAQ:PGNXProgenics Pharmaceuticals Inc
15/04/202016:16Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202012:17Business WireADDING MULTIMEDIA Velan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/04/202010:00Business WireVelan Capital Agrees to Support Merger of Lantheus and ProgenicsNASDAQ:PGNXProgenics Pharmaceuticals Inc
19/03/202010:06Edgar (US Regulatory)Proxy Statement - Merger or Acquistion (definitive) (defm14a)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202017:08Edgar (US Regulatory)Annual Report (10-k)NASDAQ:PGNXProgenics Pharmaceuticals Inc
13/03/202009:30GlobeNewswire Inc.PROGENICS PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTSNASDAQ:PGNXProgenics Pharmaceuticals Inc
20/02/202013:30Business WireLantheus and Progenics Agree to Amended Transaction TermsNASDAQ:PGNXProgenics Pharmaceuticals Inc
14/02/202015:42Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PGNXProgenics Pharmaceuticals Inc
06/02/202010:30GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentations at the 2020 American Society of Clinical Oncology Genitourinary Cancers Sym...NASDAQ:PGNXProgenics Pharmaceuticals Inc
21/01/202018:15GlobeNewswire Inc.Progenics Pharmaceuticals Provides Update on Reconstituted Board’s Ongoing Strategic ReviewNASDAQ:PGNXProgenics Pharmaceuticals Inc
16/01/202011:10GlobeNewswire Inc.Progenics Pharmaceuticals Announces Presentation at the 2020 SNMMI Mid-Winter MeetingNASDAQ:PGNXProgenics Pharmaceuticals Inc
23/12/201909:00GlobeNewswire Inc.Progenics Pharmaceuticals Announces Phase 3 CONDOR Trial of PyL™ in Prostate Cancer Achieved Primary EndpointNASDAQ:PGNXProgenics Pharmaceuticals Inc
22/12/201919:00GlobeNewswire Inc.Progenics Pharmaceuticals to Announce and Host a Conference Call to Discuss Top Line Results from Phase 3 CONDOR Trial of PyL...NASDAQ:PGNXProgenics Pharmaceuticals Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PGNX

Seu Histórico Recente

AMEX
EFIV
SPDR S&P 500 Esg ETF
BOV
BAAX39Q
Banco B3
NASDAQ
MTOH
Metrocall
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados